d-alpha tocopherol has been researched along with Hallervorden-Spatz Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez-Córdoba, M; Cilleros-Holgado, P; Munuera-Cabeza, M; Piñero-Pérez, R; Povea-Cabello, S; Reche-López, D; Sánchez-Alcázar, JA; Suárez-Carrillo, A; Suárez-Rivero, JM; Talaverón-Rey, M; Villalón-García, I | 1 |
1 other study(ies) available for d-alpha tocopherol and Hallervorden-Spatz Disease
| Article | Year |
|---|---|
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels.
Topics: Carbon-Sulfur Lyases; Humans; Iron; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Thiamine; Vitamin E | 2022 |